Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Diagn Microbiol Infect Dis. 2011 Apr;69(4):357–362. doi: 10.1016/j.diagmicrobio.2010.10.013

Table 3.

Treatment**

Total n=51 Survivors n=35 Non-survivors n=16 p*
Time to active therapy, days, mean ± SD 2.5 ± 2.2 2.6 ± 2.2 2.1 ± 2.1
Tigecycline, n (%) 47 (92) 33 (94) 14 (88)
-Duration, days, mean ± SD 14.8±11.1 19.0±10.7 5.6±10.6 .001
Colistin, n (%) 19 (37) 13 (39) 6 (38)
-Duration, days, mean ± SD 3.14±5.1 3.5±5.6 2.3±4.0
Amikacin, n (%) 24 (47) 14 (40) 10 (63)
-Duration, days, mean ± SD 3.7±7.0 4.2±8.2 2.5±3.3
Gentamicin, n (%) 2 (4) 2 (6) 0 (0)
-Duration, days, mean ± SD 0.35±2.3 0.35±2.3 -
**

Includes antibiotics given at any time after first positive blood culture.

*

univariate analysis.

SD: standard deviation.